The Business Research Company’s Multiplex Assays Global Market Report 2023is the most detailed report available on the market, including broad forecast periods and multiple geographies. The reportcovers the historic period – 2010-2021, and the forecast period – 2023-2032. The Multiplex Assays Global Market Report 2023evaluates multiplex assays market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request AFree Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=8678&type=smp

The global multiplex assays market is expected to grow from $4,365.4 million in 2026 at a CAGR of 7.7%, and to $6,312.6 million in 2031 at a CAGR of 7.7%.The rise in funding from governments and private organizations is expected to drive the market for multiplex assays in the forecast period. Several public and private investments are being made to develop multiplex assays and to address the challenges posed by the COVID-19 pandemic. The COVID-19 testing boom fueled a rise in consolidation and merger and acquisition deals start in 2021. For example, in March 2021, Roche, a Swiss healthcare organization, announced to acquire GenMark Diagnostics, a US-based supplier of multiplex molecular diagnostic products, to expand its multiplex testing capabilities. In January 2021, Thermo Fisher Scientific announced to acquire Mesa Biotech, a point-of-care molecular diagnostics company, for $450 million. In January 2021, PerkinElmer, a US-based diagnostics company, announced to acquire Oxford Immunotec, a UK-based diagnostics company, for around $591 million. Therefore, the rise in funding for multiplex technology development will positively impact the market for multiplex assays, going forward.

Get More Information On The Multiplex Assays Market Report:
https://www.thebusinessresearchcompany.com/report/multiplex-assays-market

The multiplex assays market segments in the report are:
1) By Type: Protein-Based Multiplex Assays; Nucleic Acid-Based Multiplex Assays; Other Types
2) By Identification Technology: Flow Cytometry; Multiplex Real-Time PCR; Other Identification Technologies
3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Luminescence; Fluorescence; Other Detection Technologies
4) By Application: Research And Development; Clinical Diagnostics
5) By End User: Pharmaceutical And Biotechnology Companies; Hospitals And Research Institutes; Reference Laboratories; Other End-Users

The table of contents in TBRC’s multiplex assays market report includes:
1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
………………………………
19. Company Profiles
20. Key Mergers And Acquisitions
21. Opportunities And Strategies
22. Multiplex Assays Market, Conclusions And Recommendations
23. Appendix

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Twitter:https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog:https://blog.tbrc.info/

Healthcare Blog:https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model